LYON, France–(BUSINESS WIRE)–Regulatory News:
Adocia (Euronext Paris: FR0011184241 – ADOC) (Paris:ADOC), a clinical-stage biopharmaceutical company specializing in the development of innovative formulations of proteins and...
ChatGPT Proves AI Is Finally Mainstream—and Things Are Only Going to Get WeirderJames Vincent | The Verge“OpenAI has previously sold access to GPT-3 as...
TSUKUBA, Japan, Dec 9, 2022 - (ACN Newswire) - A biocompatible polymer could help deliver vaccines and drugs with reduced risk of the rare dangerous adverse reaction called...
IMV’s common shares expected to begin trading on a split-adjusted basis on December 13, 2022
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$IMV #DeliveryPlatform–IMV Inc. (the...
SINGAPORE, Dec 6, 2022 - (ACN Newswire) - Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research...
Biotech Labs Are Using AI Inspired by DALL-E to Invent New DrugsWill Douglas Heaven | MIT Technology Review“These protein generators can be directed to...
DARTMOUTH, Nova Scotia, & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$IMV #DeliveryPlatform–IMV Inc. (“IMV” or the “Company”) (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of...